Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Hereditary spastic paraplegias are a group of rare neurodegenerative disorders characterized by progressive spastic paraparesis. Spastic paraplegia 80 (SPG80) is an autosomal dominant form linked to heterozygous mutations in UBAP1 and classified as spastic paraplegia 80, autosomal dominant.
Genetic studies have identified truncating UBAP1 variants in SPG80 probands. A novel heterozygous c.279del (p.Ser94ValfsTer9) variant segregated in eight affected members of a single family (PMID:32222895). Exome sequencing in four additional families revealed three loss-of-function variants, including c.535G>T (p.Glu179Ter) (PMID:31515522).
Subsequent analyses in five unrelated families uncovered a recurrent two-base-pair deletion c.426_427del (p.Lys143SerfsTer15) present in four families and a de novo c.475_476delTT (p.Phe159Ter) in another (PMID:31696996). Two more truncating alleles, c.468_469del (p.Ala157_Gly186del) and c.512T>G (p.Leu171Ter), were described in two families (PMID:34191852).
All variants are predicted to escape nonsense-mediated decay, yielding truncated UBAP1 proteins lacking ESCRT-I binding domains. Segregation analyses confirm autosomal dominant transmission in at least 10 additional affected relatives (PMID:32222895; PMID:31696996).
Functional assays demonstrate that mutant UBAP1 fails to bind ubiquitin or localize to endosomal membranes, impairing neurite outgrowth in neuronal models (PMID:31515522). A Ubap1+/E176Efx23 knock-in mouse recapitulates progressive hind limb dysfunction, spinal motor neuron loss, and ubiquitin accumulation, mirroring the human phenotype (PMID:35962060).
These findings establish haploinsufficiency of UBAP1 as the pathogenic mechanism underlying autosomal dominant SPG80. Genetic testing for truncating UBAP1 variants is recommended for patients presenting with progressive spastic paraparesis.
Gene–Disease AssociationStrong19 probands across 12 unrelated families, segregation in at least 10 affected relatives (PMID:32222895; PMID:31696996), and concordant LoF functional data Genetic EvidenceStrongMultiple heterozygous truncating variants identified in 19 probands from separate families with segregation in 10 relatives Functional EvidenceStrongCellular assays show loss of ubiquitin binding and endosomal targeting (PMID:31515522) and a knock-in mouse model reproduces SPG80 phenotypes (PMID:35962060) |